ProfileGDS4718 / 1554077_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 90% 66% 90% 85% 83% 81% 88% 89% 89% 88% 88% 85% 82% 83% 83% 87% 79% 86% 58% 91% 88% 91% 87% 86% 84% 87% 72% 88% 79% 85% 78% 88% 90% 80% 79% 80% 87% 88% 63% 88% 79% 81% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9205888
GSM549102patient 115, normal, homogenized [OPG study]9.1632490
GSM549104patient 119, normal, homogenized [OPG study]6.5770966
GSM549108patient 138, normal, homogenized [OPG study]9.131490
GSM549119patient 077, normal, homogenized [OPG study]8.4355585
GSM549133patient 032, cancer, homogenized [OPG study]8.3478383
GSM549139patient 042, cancer, homogenized [OPG study]7.9751381
GSM549099patient 107, normal, homogenized [OPG study]8.8878388
GSM549109patient 139, normal, homogenized [OPG study]9.0497189
GSM549110patient 046, normal, homogenized [OPG study]9.1113889
GSM549114patient 063, normal, homogenized [OPG study]8.9547288
GSM549122patient 082, normal, homogenized [OPG study]8.9540888
GSM549134patient 033, cancer, homogenized [OPG study]8.5509985
GSM549136patient 036, cancer, homogenized [OPG study]8.1779982
GSM549140patient 044, cancer, homogenized [OPG study]8.3361983
GSM549111patient 047, normal, homogenized [OPG study]8.2682683
GSM549113patient 057, normal, homogenized [OPG study]8.9373587
GSM549132patient 031, cancer, homogenized [OPG study]7.7381879
GSM549137patient 038, cancer, homogenized [OPG study]8.543886
GSM549142patient 047, cancer, homogenized [OPG study]6.0937358
GSM549100patient 110, normal, homogenized [OPG study]9.3235291
GSM549107patient 135, normal, homogenized [OPG study]8.97988
GSM549115patient 068, normal, homogenized [OPG study]9.6768591
GSM549116patient 072, normal, homogenized [OPG study]8.8394687
GSM549120patient 078, normal, homogenized [OPG study]8.6524186
GSM549131patient 030, cancer, homogenized [OPG study]8.4654884
GSM549118patient 074, normal, homogenized [OPG study]8.8505687
GSM549129patient 027, cancer, homogenized [OPG study]7.1335872
GSM549123patient 088, normal, homogenized [OPG study]8.8773188
GSM549124patient 006, cancer, homogenized [OPG study]7.6981979
GSM549126patient 015, cancer, homogenized [OPG study]8.3842385
GSM549128patient 025, cancer, homogenized [OPG study]7.681378
GSM549103patient 117, normal, homogenized [OPG study]8.8037788
GSM549117patient 073, normal, homogenized [OPG study]9.3179590
GSM549138patient 041, cancer, homogenized [OPG study]7.9180980
GSM549141patient 045, cancer, homogenized [OPG study]7.9131179
GSM549130patient 028, cancer, homogenized [OPG study]7.8376780
GSM549101patient 111, normal, homogenized [OPG study]8.6165487
GSM549105patient 128, normal, homogenized [OPG study]8.7917188
GSM549106patient 134, normal, homogenized [OPG study]6.3426863
GSM549112patient 048, normal, homogenized [OPG study]8.9167588
GSM549125patient 011, cancer, homogenized [OPG study]7.7193779
GSM549127patient 024, cancer, homogenized [OPG study]7.9987781
GSM549135patient 035, cancer, homogenized [OPG study]7.9395880